180 related articles for article (PubMed ID: 19268700)
41. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
Kobayashi T; Ishida T; Okada Y; Ise S; Harashima H; Kiwada H
Int J Pharm; 2007 Feb; 329(1-2):94-102. PubMed ID: 16997518
[TBL] [Abstract][Full Text] [Related]
42. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
43. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
Kars MD; Işeri OD; Gunduz U; Molnar J
Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
[TBL] [Abstract][Full Text] [Related]
45. Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil.
Zhang L; Yang Y; Wei XY; Shi YR; Liu HY; Niu RF; Hao XS
J Exp Clin Cancer Res; 2007 Jun; 26(2):201-7. PubMed ID: 17725099
[TBL] [Abstract][Full Text] [Related]
46. [Development of a K562 multidrug-resistant cell line and study on proteins with altered expression].
Wang Y; Cao J; Zeng S
Shi Yan Sheng Wu Xue Bao; 2003 Oct; 36(5):342-6. PubMed ID: 14724945
[TBL] [Abstract][Full Text] [Related]
47. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
[TBL] [Abstract][Full Text] [Related]
48. Modulation of cancer cell multidrug resistance by an extract of Ficus citrifolia.
Simon PN; Chaboud A; Darbour N; Di Pietro A; Dumontet C; Lurel F; Raynaud J; Barron D
Anticancer Res; 2001; 21(2A):1023-7. PubMed ID: 11396135
[TBL] [Abstract][Full Text] [Related]
49. The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines: implications for overcoming multidrug resistance towards leukaemia K562/DOX cells.
Tarasiuk J; Majewska E; Seksek O; Rogacka D; Antonini I; Garnier-Suillerot A; Borowski E
Biochem Pharmacol; 2004 Nov; 68(9):1815-23. PubMed ID: 15450947
[TBL] [Abstract][Full Text] [Related]
50. Endogenous interleukin 6 conveys resistance to cis-diamminedichloroplatinum-mediated apoptosis of the K562 human leukemic cell line.
Dedoussis GV; Mouzaki A; Theodoropoulou M; Menounos P; Kyrtsonis MC; Karameris A; Maniatis A
Exp Cell Res; 1999 Jun; 249(2):269-78. PubMed ID: 10366426
[TBL] [Abstract][Full Text] [Related]
51. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.
Shen X; Chen G; Zhu G; Fong WF
Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827
[TBL] [Abstract][Full Text] [Related]
52. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
Yoshida M; Matsui Y; Ikarashi Y; Usui T; Osada H; Wakasugi H
Anticancer Res; 2007; 27(2):729-36. PubMed ID: 17465195
[TBL] [Abstract][Full Text] [Related]
53. Reversal of P-glycoprotein-mediated multidrug resistance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs.
Angelini A; Iezzi M; Di Febbo C; Di Ilio C; Cuccurullo F; Porreca E
Oncol Rep; 2008 Oct; 20(4):731-5. PubMed ID: 18813811
[TBL] [Abstract][Full Text] [Related]
54. Ionic currents in multidrug resistant K562 human leukemic cells.
Assef YA; Cavarra SM; Damiano AE; Ibarra C; Kotsias BA
Leuk Res; 2005 Sep; 29(9):1039-47. PubMed ID: 16038730
[TBL] [Abstract][Full Text] [Related]
55. Gamma-linolenic acid therapy of human glioma-a review of in vitro, in vivo, and clinical studies.
Das UN
Med Sci Monit; 2007 Jul; 13(7):RA119-31. PubMed ID: 17599036
[TBL] [Abstract][Full Text] [Related]
56. 20S-protopanaxadiol inhibits P-glycoprotein in multidrug resistant cancer cells.
Zhao Y; Bu L; Yan H; Jia W
Planta Med; 2009 Aug; 75(10):1124-8. PubMed ID: 19291609
[TBL] [Abstract][Full Text] [Related]
57. The activity of latent benzoperimidine esters to inhibit P-glycoprotein and multidrug resistance-associated protein 1 dependent efflux of pirarubicin from several lines of multidrug resistant tumor cells.
Głowacka-Rogacka D; Arciemiuk M; Kupiec A; Bontemps-Gracz MM; Borowski E; Tarasiuk J
Cancer Detect Prev; 2004; 28(4):283-93. PubMed ID: 15350632
[TBL] [Abstract][Full Text] [Related]
58. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells.
Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ
Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007
[TBL] [Abstract][Full Text] [Related]
59. New uses for old drugs: pharmacophore-based screening for the discovery of P-glycoprotein inhibitors.
Palmeira A; Rodrigues F; Sousa E; Pinto M; Vasconcelos MH; Fernandes MX
Chem Biol Drug Des; 2011 Jul; 78(1):57-72. PubMed ID: 21235729
[TBL] [Abstract][Full Text] [Related]
60. Effects of non-cytotoxic drugs on the growth of multidrug-resistance human gastric carcinoma cell line.
Wang CH; Zheng WB; Qiang O; Tang CW
J Dig Dis; 2009 May; 10(2):91-8. PubMed ID: 19426390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
